Aldactone vs. Myorisan

Summary

We compare the side effects and drug effectiveness of Aldactone and Myorisan. The study is created by eHealthMe based on reports of 127,266 people who take Aldactone and Myorisan, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers. Choose a tool to use eHealthMe.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How the study uses the data?

The study is based on spironolactone and isotretinoin (the active ingredients of Aldactone and Myorisan, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered.

What is Aldactone?

Aldactone has active ingredients of spironolactone. It is often used in acne. Check the latest outcomes from 31,026 Aldactone users, or browse all drugs.

What is Myorisan?

Myorisan has active ingredients of isotretinoin. It is often used in acne. Check the latest outcomes from 1,587 Myorisan users, or browse all drugs.

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.

Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

Data + Experience to manage medications:

On eHealthMe, we believe health data should work with individual experience to improve drug outcomes. With our Ginger Health app, you can get one-to-one mobile support from people like you. Patients and caregivers can get paid with their health care experience as a Care Guide. Learn more about Care Guides.


On Mar, 13, 2019

127,266 people who take Aldactone and Myorisan are studied.


Number of reports submitted per year:

Aldactone vs Myorisan drug comparison reports.

Drugs in this study:

  • Myorisan (isotretinoin)
  • Aldactone (spironolactone)

Most common side effects:

Aldactone:
  1. Inflammatory Bowel Disease
  2. Depression
  3. Colitis Ulcerative (inflammation of colon with ulcer)
  4. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract)
  5. Irritable Bowel Syndrome
  6. Anxiety
  7. Colitis (inflammation of colon)
  8. Dry Skin
  9. Suicidal Ideation
  10. Headache (pain in head)
Myorisan:
  1. Dyspnoea (difficult or laboured respiration)
  2. Nausea (feeling of having an urge to vomit)
  3. Fatigue (feeling of tiredness)
  4. Diarrhoea
  5. Hyperkalaemia (damage to or disease of the kidney)
  6. Renal Failure Acute (rapid kidney dysfunction)
  7. Vomiting
  8. Asthenia (weakness)
  9. Anaemia (lack of blood)
  10. Hypotension (abnormally low blood pressure)

Most common side effects experienced by people in long term use:

Aldactone:
  1. Inflammatory Bowel Disease
  2. Colitis Ulcerative (inflammation of colon with ulcer)
  3. Depression
  4. Crohn's Disease (condition that causes inflammation of the gastrointestinal tract)
  5. Irritable Bowel Syndrome
  6. Intestinal Obstruction
  7. Injury
  8. Anxiety
  9. Intestinal Haemorrhage (bleeding from intestine)
  10. Gastrointestinal Injury (injury to gastrointestinal tract)
Myorisan:
  1. Hyperkalaemia (damage to or disease of the kidney)
  2. Renal Failure Acute (rapid kidney dysfunction)
  3. Dehydration (dryness resulting from the removal of water)
  4. Renal Failure (kidney dysfunction)
  5. Pain
  6. Vomiting
  7. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  8. Cardiac Failure
  9. Dyspnoea (difficult or laboured respiration)
  10. Renal Impairment (severely reduced kidney function)

Drug effectiveness:

Aldactone:
  • not at all: 3.99 %
  • somewhat: 15.72 %
  • moderate: 23.92 %
  • high: 35.19 %
  • very high: 21.18 %
Myorisan:
  • not at all: 5.23 %
  • somewhat: 22.51 %
  • moderate: 31.76 %
  • high: 27.74 %
  • very high: 12.76 %

Do you take Aldactone or Myorisan?

You are not alone:



Related publications that referenced our studies

Related studies:

Mobile peer-to-peer support:

Ginger Health (developed by eHealthMe) has millions of focused support groups to join: each group for one drug side effect, symptom, drug or condition. You can also follow Care Guides who "have been there" to help you meet care goals and improve day-to-day life.



Recent publications that referenced eHealthMe studies


DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.